123 related articles for article (PubMed ID: 5646850)
1. Studies on therapeutic effectiveness of drugs with tumor weight and survival time indices of Walker 256 carcinosarcoma.
DeWys WD; Humphreys SR; Goldin A
Cancer Chemother Rep; 1968 Feb; 52(2):229-42. PubMed ID: 5646850
[No Abstract] [Full Text] [Related]
2. Potentials for the use of heparin in combination with radiation therapy, Experience with ascitic Walker 256 carcinosarcoma in weanling rats.
Torpie RJ
J Med; 1974; 5(1):133-48. PubMed ID: 4524856
[No Abstract] [Full Text] [Related]
3. Effects of guinea-pig serum on the Walker 256 carcinosarcoma.
Dolowy WC; Schrek R; Henson D; Cornet J; Brown E
Nature; 1968 Jun; 218(5146):1028-31. PubMed ID: 5656616
[No Abstract] [Full Text] [Related]
4. [Ultrastructural changes in cells of the original tumors, metastases and stroma of rat walker-256 carcinosarcoma treated with a heparin complex with urea].
Kolomina SM; Chentsov IuS; Pogodina LS; Kudriashov BA; Kalishevskaia TM
Tsitol Genet; 1979; 13(1):8-15. PubMed ID: 442204
[No Abstract] [Full Text] [Related]
5. Toxicity of intrathecally administered cytotoxic drugs and their antitumor activity against an intrathecal Walker 256 carcinosarcoma model for meningeal carcinomatosis in the rat.
Kooistra KL; Rodriguez M; Powis G
Cancer Res; 1989 Feb; 49(4):977-82. PubMed ID: 2912564
[TBL] [Abstract][Full Text] [Related]
6. Feeding response to change in absorbable food fraction during growth of Walker 256 carcinosarcoma.
Morrison SD
Cancer Res; 1972 May; 32(5):968-72. PubMed ID: 5017743
[No Abstract] [Full Text] [Related]
7. [Comparative studies of clinically equivalent doses of various cytostatic agents on the mouse Ehrlich ascites carcinoma and rat Walker carcinosarcoma 256 in vivo and in cell culture (in vitro)].
Matthias M; Tanneberger S; Gummel H
Arch Geschwulstforsch; 1970; 36(3):240-6. PubMed ID: 5498278
[No Abstract] [Full Text] [Related]
8. [Screening of substances and extracts of plant origin in Walker carcinosarcoma 256].
Sampaio MR; De Oliveira MM
An Acad Bras Cienc; 1975; 47(1):149-53. PubMed ID: 1233885
[TBL] [Abstract][Full Text] [Related]
9. [The effect of ferromagnet particles on the growth of Walker carcinosarcoma 256 in Wistar rats].
Volkonskiĭ VA
Eksp Onkol; 1990; 12(2):74-6. PubMed ID: 2318139
[TBL] [Abstract][Full Text] [Related]
10. Antitumor activity of a polychlorinated biphenyl mixture, Aroclor 1254, in rats inoculated with Walker 256 carcinosarcoma cells.
Kerkvliet NI; Kimeldorf DJ
J Natl Cancer Inst; 1977 Sep; 59(3):951-5. PubMed ID: 408506
[No Abstract] [Full Text] [Related]
11. Ultrastructural changes induced in Walker carcinosarcoma by treatment with dihematoporphyrin ester and light in animals with diabetes mellitus.
Dima VF; Ionescu MD
Roum Arch Microbiol Immunol; 2000; 59(1-2):119-30. PubMed ID: 11845470
[TBL] [Abstract][Full Text] [Related]
12. Antitumor activity of cis-dihalogenobis(1-phenyl-1,3-butanedionato) titanium(IV) compounds against Walker 256 carcinosarcoma. A new class of antineoplastic agents.
Keller HJ; Keppler B; Schmähl D
Arzneimittelforschung; 1982; 32(8):806-7. PubMed ID: 6890355
[TBL] [Abstract][Full Text] [Related]
13. [Kinetics of regression and relapse of Walker carcinosarcoma treated with alkylating agents].
Parkanskiĭ MN; Konovalova NP; Emanuél' N
Izv Akad Nauk SSSR Biol; 1973; (1):144-6. PubMed ID: 4218850
[No Abstract] [Full Text] [Related]
14. [Action of 3,5,3'-triiodothyronine (T3) on Walker's 256 carcinosarcoma development].
Feder D; Bueno MA; Krybus J; Novak A; Cabral M; Andrade Júnior AF; Zyngier S
Rev Hosp Clin Fac Med Sao Paulo; 1992; 47(3):142-5. PubMed ID: 1340589
[TBL] [Abstract][Full Text] [Related]
15. Potentiation by clofibrate of in-vivo tumor inhibition by hydrazine sulfate and cytotoxic agents, in Walker 256 carcinosarcoma.
Gold J
Cancer Biochem Biophys; 1978; 3(1):41-5. PubMed ID: 552898
[TBL] [Abstract][Full Text] [Related]
16. [Studies on the solid Walker-carcinosarcoma 256 in the rat during administration of cytostatics].
Mattern J; Volm M; Wayss K
Arzneimittelforschung; 1972 Oct; 22(10):1721-2. PubMed ID: 4677063
[No Abstract] [Full Text] [Related]
17. Alteration of blood-CSF barrier by tumor invasion into the meninges.
Ushio Y; Shimizu K; Aragaki Y; Arita N; Hayakawa T; Mogami H
J Neurosurg; 1981 Sep; 55(3):445-9. PubMed ID: 6943305
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Dunning asc itic leukemia and Walker 256 carcinosarcoma with cis-diamminedichloroplatinum (NSC-119875).
Kociba RJ; Sleight SD; Rosenberg B
Cancer Chemother Rep; 1970 Oct; 54(5):325-8. PubMed ID: 5514621
[No Abstract] [Full Text] [Related]
19. [Some characteristics of the biological action of D, L-1,4-dibromo-1,4-dideoxy-2,3-butanediol].
Miuller NR; Remizov AL; Belogorodskiĭ VV; Filov VA
Farmakol Toksikol; 1975; 38(5):590-1. PubMed ID: 1191387
[TBL] [Abstract][Full Text] [Related]
20. [The influence of light and darkness on male and female rats with Walker carcinosarcoma].
Tessmann D; Göcke H; Salditt G
Arch Geschwulstforsch; 1972; 39(4):300-3. PubMed ID: 5069159
[No Abstract] [Full Text] [Related]
[Next] [New Search]
